Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Laurus Labs Ltd. Share Price
Day's Range
Low
₹2,067.40
High
₹2,125.00
Price Summary
| Previous Close | ₹2,113.10 |
|---|---|
| Day's Range | ₹2,067.40 - ₹2,125.00 |
| Open | ₹2,075.00 |
| 52 Week Range | ₹917.95 - ₹2,089.00 |
| Volume | 22,34,114 |
| Market Cap | ₹0.11 |
| Previous Close | ₹2,119.45 |
|---|---|
| Day's Range | ₹2,067.35 - ₹2,126.40 |
| Open | ₹2,072.50 |
| 52 Week Range | ₹913.35 - ₹2,087.00 |
| Volume | 81,132 |
| Market Cap | ₹0.11 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 47,209.06 |
|---|---|
| Market Cap (₹ in Mn) | 0.11 |
| Dividend Yield(%) | 0.10 |
| Price/Earning (TTM) | 101.80 |
| TTM EPS (₹) | 20.24 |
| P/E Ratio | 60.25 |
| Book Value(₹) | 19.74 |
| PAT Margin (%) | 13.06 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 18.20 |
| Trade Value ( ₹ in Lacs) | 1,719.55 |
|---|---|
| Market Cap (₹ in Mn) | 0.11 |
| Dividend Yield(%) | 0.10 |
| Price/Earning (TTM) | 101.80 |
| TTM EPS (₹) | 20.24 |
| P/E Ratio | 60.25 |
| Book Value(₹) | 19.74 |
| PAT Margin (%) | 13.06 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 18.20 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 14327.5 | 55539.6 |
| Expenses | N/A | N/A |
| PBT | 2114.4 | 4882.2 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 1579.4 | 3583.4 |
About Laurus Labs Ltd.
| Founded | 2005 |
|---|---|
| NSE Symbol | LAURUSLABS |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,18,204.09 | 1,764.65 | 1,583.70 - 1,583.70 |
| Divi's Laboratories Ltd. | 2,40,780.00 | 9,418.50 | 5,647.50 - 5,647.50 |
| Torrent Pharmaceuticals Ltd. | 1,73,828.11 | 4,591.85 | 3,532.60 - 3,532.60 |
| Zydus Lifesciences Ltd. | 1,15,520.92 | 1,171.95 | 835.50 - 835.50 |
| Lenskart Solutions Ltd. | 1,13,228.83 | 671.40 | 0.00 - 0.00 |
| Apollo Hospitals Enterprise Ltd. | 1,12,367.71 | 7,854.25 | 6,696.50 - 6,696.50 |
| Laurus Labs Ltd. | 1,11,304.32 | 2,119.45 | 917.95 - 917.95 |
| Cipla Ltd. | 1,09,304.89 | 1,361.50 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,08,758.84 | 1,319.35 | 1,101.00 - 1,101.00 |
| Mankind Pharma Ltd. | 95,082.98 | 2,516.00 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Laurus Labs submits analyst meet intimation
Sai Parenterals informs about board meeting
OneSource Specialty Pharma informs about press release
Hester Biosciences informs about completion of tenure of independent director
Pursuant to provisions of Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Hester Biosciences has informed that, Ameetkumar Desai (DIN: 00007116) has informed the Company of his decision not to seek re-appointment for a second consecutive term as an Independent Director upon completion of his current first tenure on 27 October 2026. Consequently, effective closure of business hours on 27 October 2026, Ameetkumar Desai ceases to be an Independent Director of the Company. The Company placed on record its appreciation for the valuable contribution and support provided him during his association with the Company. The details as required under SEBI Listing Regulation read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30 January 2026, are enclosed.
The above information is a part of company’s filings submitted to BSE.
Chandra Bhagat Pharma informs about disclosure
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Laurus Labs Ltd. is ₹2,113.10 as of 2026-10-27.
The market capitalisation of Laurus Labs Ltd. is ₹111,304.32 as of 2026-10-26.
The 1-year return of Laurus Labs Ltd. is 1,186.70% as of 2026-10-27.
The P/E ratio of Laurus Labs Ltd. is 60.25 as of 2026-10-27.
The 52-week high and low of Laurus Labs Ltd. are ₹2,089.00 and ₹917.95, respectively, as of 2026-10-27.
People Also Ask
Laurus Labs Ltd. provides active pharmaceutical ingredients, generic formulations and contract‑development/manufacturing services, with strengths in antivirals, oncology and chronic therapies.
Laurus Labs Ltd. collaborates via API and formulation supply agreements and CDMO partnerships with global generic and branded pharma companies that serve hospitals worldwide.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
